GlassScriptPhysician profile
Leonard Doberne
NPI 1558447847
$2,563.69
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $178 · 2021: $727 · 2022: $340.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $424.91 | 2019-2022 | |
| Novo Nordisk INC | $302.63 | 2019-2022 | |
| Corcept Therapeutics | $261.24 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $231.18 | 2019-2022 | |
| Amgen INC. | $195.32 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.83 | 2019-2022 | |
| Radius Health, INC. | $138.91 | 2019-2022 | |
| Abbvie INC. | $124.68 | 2019-2022 | |
| Zealand Pharma US, INC. | $99.92 | 2021 | |
| Becton, Dickinson and Company | $96.13 | 2021-2022 | |
| Abbott Laboratories | $81.26 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $68.52 | 2019-2022 | |
| Insulet Corporation | $58.23 | 2019 | |
| Horizon Therapeutics Plc | $55.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $53.04 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $52.27 | 2019-2020 | |
| Shire North American Group INC | $49.08 | 2019 | |
| Mannkind Corporation | $36.98 | 2019 | |
| Ibsa Pharma INC. | $28.36 | 2020 | |
| Xeris Pharmaceuticals, INC. | $17.04 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Doberne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.